Advanced Search
Schroder Adveq

Schroder Adveq

Schroder Adveq (formerly Adveq) is an asset manager investing in private equity and real asset funds globally.

Founded in 1997, Schroder Adveq is an asset manager investing in private equity globally. Schroder Adveq invests in all private equity strategies, including venture capital, growth capital, buyout, and turnarounds through primaries, secondaries, and direct-/co-investments.


Founded in 1997, Adveq offers specialized investment solutions which allow the firm’s clients to access select private market segments globally. To date, Adveq has invested in more than 400 funds on behalf of its clients and generated consistent returns throughout economic cycles. Adveq’s client base comprises institutional investors such as pension funds, insurance companies, family offices and other financial institutions located in Europe, North America and the Asia-Pacific region. Many of Adveq’s investors are repeat, long-term clients for private market investing. Adveq has offices in Zurich, Frankfurt, London, New York, Beijing, Shanghai, and Hong Kong, as well as an agent relationship in Sydney.

As of July 31, 2017, Adveq Management AG operates as a subsidiary of Schroders plc. Adveq has been renamed Schroder Adveq through acquisition, which was announced on 20 April 2017.


The firm prefers to invest in growth capital, small/mid-market buyout and other opportunities. It seeks to invest in medicine, vaccines, medical appliances, technology, and technology-enabled services, clean energy, and health and healthcare sectors. It seeks to invest across the globe with a focus on North America, Asia / Pacific, and Europe. It also prefers to invest in China, German-speaking region, the United Kingdom, France, Benelux, and the Nordics; United States; and Canada. The firm seeks to make control investments.

For fund of funds, it seeks to invest in venture capital, private equity, distressed/turnaround, developmental capital funds, and special situation funds.

Adveq has made 7 investments. They invested $18M in Rethink Robotics on Jan 5, 2017.

Adveq has raised a total of $816.6M across 2 funds, one of them being Adveq Europe VI. This fund was announced on Dec 12, 2016, and raised a total of €462M.

Adveq has $11.5M in revenue annually. Adveq competes with AlpInvest Partners, Capital Dynamics, and Capvis Equity.


Adveq specializes in Venture and growth capital, Buyouts (value/transformational, specialist), Turnarounds, Real assets, Primaries, Secondaries, Co-investments, and Advisory services.

Schroder Adveq’s client base comprises institutional investors such as pension funds, insurance companies, endowments, family offices, and other financial institutions located in Europe, North America, and the Asia-Pacific region. For many of its clients, Schroder Adveq is a long-term partner for investments in private equity.


November 11, 2018
AMAL Therapeutics

Series B - II


October 9, 2018
ImmunOs Therapeutics

Seed - II

July 15, 2018
Pliant Therapeutics

Series B


July 11, 2018
Nohla Therapeutics

Series B - II


June 18, 2018
Decibel Therapeutics

Series C


January 4, 2017
Rethink Robotics

Series E - Rethink Robotics


December 11, 2016
Adveq Europe VI


October 23, 2016

Venture Round - AEVI


October 16, 2016

Series D -


May 3, 2016

Series D -


Page 1 of 2


Further reading

Documentaries, videos and podcasts



June 10, 2020
Company attracts three experienced industry executives to lead preclinical and clinical development as well as finance and operations


Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.